South Korea Backs Remdesivir for Coronavirus, Urges Caution With Dexamethasone - (International Business Times via NewsPoints Desk)

  • South Korea has added Gilead Sciences' remdesivir to its COVID-19 treatment guidelines and has urged caution in regards to using the steroid therapy dexamethasone, as reported by the International Business Times.

  • The country's updated guidelines come after a study showed that dexamethasone reduced deaths in severely ill COVID-19 patients. They advised doctors to take caution until a full study is published.

  • "It seems appropriate to administer (dexamethasone), limited to severe cases with the acute respiratory syndrome, as the doctor monitors the patient's condition," said Kim Young-ok, director-general of pharmaceutical safety bureau at the Ministry of Food and Drug Safety.

  • There was enough domestic supply of the dexamethasone, with production of approximately 43 million tablets and 60 million injection ampoules a year, said Kim.

  • Meanwhile, Korean health authorities also advised the dropping of hydroxychloroquine after a study found the malaria drug did not provide any benefit.

To read more NewsPoints articles, click here.